Advertisement
INSP vs VIVO
Which Stock Would AI Choose? Inspire Medical Systems (INSP) vs. VivoPower PLC (VIVO) Stock Comparison
Key Takeaways
- INSP, a medical device leader in obstructive sleep apnea treatments, reported Q1 2026 revenue of $204.6 million, beating estimates, but lowered full-year guidance due to reimbursement challenges, leading to recent share price declines.
- VIVO, focused on sustainable energy and AI data center infrastructure, achieved EBITDA profitability with $31 million revenue from a recent Norway data center acquisition and targets further uplift from grid flexibility programs.
- INSP trades at around $46 with a $1.3 billion market cap in the healthcare sector, showing YTD gains of 50% but high volatility amid lowered analyst targets averaging $72.
- VIVO trades near $3.3 with a $55 million market cap in technology-software infrastructure, up 45% YTD, driven by AI-related expansions despite smaller scale and negative prior EBITDA.
- Recent momentum favors VIVO on positive catalysts like data center deals, while INSP faces headwinds from coding and reimbursement issues.
- Tickeron's AI tools highlight sector trends in healthcare devices and AI infrastructure, aiding relative performance analysis.
Introduction
This stock comparison examines INSP and VIVO, two distinct players navigating current market dynamics. INSP operates in the established medical devices sector, while VIVO targets high-growth sustainable energy and AI infrastructure. Traders seeking exposure to healthcare innovation or emerging tech themes, and investors assessing relative performance amid volatility, will find value in this analysis of recent trends, financials, and positioning. With broader market focus on sector rotation and catalysts, understanding their contrasts supports informed portfolio decisions.
INSP Overview and Recent Performance
Inspire Medical Systems (INSP), a medical technology company, develops and commercializes the Inspire therapy system, a minimally invasive neurostimulation treatment for obstructive sleep apnea (OSA). Headquartered in Golden Valley, Minnesota, it serves the U.S. and international markets through healthcare providers.
In recent market activity, INSP shares have faced pressure, trading around $46 within a 52-week range of $44 to $163, reflecting a market cap of approximately $1.3 billion. Year-to-date gains stand at 50%, bolstered by prior growth, but recent weeks saw declines following Q1 2026 earnings. Revenue rose 1.6% year-over-year to $204.6 million, surpassing estimates, with adjusted EPS of $0.10 beating consensus. However, the company cut full-year 2026 revenue guidance to $850 million midpoint from prior levels, citing persistent reimbursement and coding challenges with CMS (Centers for Medicare & Medicaid Services). Analysts responded by lowering price targets, averaging $72, influencing sentiment amid healthcare sector reimbursement uncertainties.
VIVO Overview and Recent Performance
VivoPower PLC (VIVO) delivers sustainable energy solutions, including electric vehicle conversions, microgrids, solar projects, and now AI data center infrastructure. Operating globally from London, its segments span electric vehicles for rugged applications, sustainable energy solutions, solar development, and digital assets, with recent emphasis on powered data centers for AI compute.
Recent market activity has propelled VIVO shares to about $3.3, within a 52-week range of $1.20 to $8.88, supporting a $55 million market cap. Year-to-date up 45%, the stock reflects positive momentum from strategic moves. Key developments include completing a $41 million acquisition of a 41.5MW energized data center in Norway, driving $31 million revenue and $10 million EBITDA, marking a shift to profitability. Further, enrollment in Statnett's demand response program targets $1.9 million annualized EBITDA uplift, with strong AI operator interest sparking lease bidding. These catalysts in the AI infrastructure space have boosted sentiment, contrasting prior losses.
Trending AI Robots
Tickeron’s Trending AI Robots page curates the top-performing AI trading bots from hundreds available, which collectively trade thousands of tickers across diverse strategies, timeframes, and market conditions. Only the most promising—selected by AI analysis for current trends like semiconductors, industrials, space, data centers, and energy—earn a spot among the 25 featured out of 351 total bots. These showcase impressive stats, including annualized returns up to +162%, win rates from 51% to 88%, and profit factors reaching 11.7, often with low-to-medium drawdowns on model portfolios. Virtual agents incorporate risk management like take-profit/stop-loss corridors, enabling copy trading without minimum balances. Exploring these bots offers insights into momentum and sector rotation outperforming benchmarks—visit Trending AI Robots to review real-time signals tailored to today's volatility.
Head-to-Head Comparison
INSP and VIVO diverge sharply in business models: INSP's established OSA therapy drives recurring revenue in healthcare (medical devices), while VIVO's pivot to AI data centers fuels growth in technology-software infrastructure via acquisitions and energy solutions.
Growth drivers contrast INSP's procedure volumes, hampered by reimbursement risks, against VIVO's catalysts like Norway expansions tapping AI demand. Recent momentum shows VIVO gaining on profitability milestones, while INSP dips post-guidance cut.
Risk factors include INSP's regulatory dependencies (high beta implied by volatility) versus VIVO's execution risks in nascent AI infra (beta -1.07, smaller cap amplifies swings). Sector exposure pits stable healthcare against volatile tech-energy hybrids, with market sentiment favoring VIVO's upside potential amid AI hype over INSP's headwinds.
Tickeron AI Verdict
Tickeron’s AI would currently lean toward VIVO, based on stronger trend consistency from recent EBITDA positivity and AI data center catalysts, offering higher relative positioning in growth sectors. INSP shows stability in revenue but trails on momentum amid guidance risks. Probabilistic edge favors VIVO for traders eyeing near-term upside, though both warrant monitoring for evolving conditions.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INSP is a Hold and VIVO is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
INSP’s FA Score shows that 0 FA rating(s) are green whileVIVO’s FA Score has 1 green FA rating(s).
- INSP’s FA Score: 0 green, 5 red.
- VIVO’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
INSP’s TA Score shows that 4 TA indicator(s) are bullish while VIVO’s TA Score has 4 bullish TA indicator(s).
- INSP’s TA Score: 4 bullish, 4 bearish.
- VIVO’s TA Score: 4 bullish, 5 bearish.
Price Growth
INSP (@Medical/Nursing Services) experienced а -20.95% price change this week, while VIVO (@Computer Communications) price change was +10.65% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.26%. For the same industry, the average monthly price growth was +1.77%, and the average quarterly price growth was -4.79%.
The average weekly price growth across all stocks in the @Computer Communications industry was +0.33%. For the same industry, the average monthly price growth was +15.37%, and the average quarterly price growth was +16.76%.
Reported Earning Dates
INSP is expected to report earnings on Aug 04, 2026.
VIVO is expected to report earnings on Jun 03, 2026.
Industries' Descriptions
@Medical/Nursing Services (+0.26% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Computer Communications (+0.33% weekly)Computer communications industry develops technology that allows computing devices to exchange data with each other using connections/data links between nodes. Common types of computer network include Cloud (IAN), Internet, Wide (WAN, Local (LAN)/Wireless(WLAN) etc. The industry is an ever-more important part of technology, and is set to become even bigger as the Internet of Things (IoT) rapidly forays into the various aspects of our lives. Cisco Systems, Inc., Palo Alto Networks, Inc. and Arista Networks, Inc., Fortinet, Inc. are some of the major computer communications companies.
| INSP | VIVO | INSP / VIVO | |
| Capitalization | 1.25B | 54.1M | 2,309% |
| EBITDA | 82.2M | -9.72M | -845% |
| Gain YTD | -52.998 | 42.163 | -126% |
| P/E Ratio | 9.85 | N/A | - |
| Revenue | 915M | 61K | 1,500,000% |
| Total Cash | 284M | N/A | - |
| Total Debt | 29.6M | N/A | - |
INSP | VIVO | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 51 | 62 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 47 Fair valued | 89 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 48 | 100 | |
PRICE GROWTH RATING 1..100 | 93 | 38 | |
P/E GROWTH RATING 1..100 | 99 | 5 | |
SEASONALITY SCORE 1..100 | 46 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
INSP's Valuation (47) in the Medical Specialties industry is somewhat better than the same rating for VIVO (89) in the Biotechnology industry. This means that INSP’s stock grew somewhat faster than VIVO’s over the last 12 months.
INSP's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as VIVO (100) in the Biotechnology industry. This means that INSP’s stock grew similarly to VIVO’s over the last 12 months.
INSP's SMR Rating (48) in the Medical Specialties industry is somewhat better than the same rating for VIVO (100) in the Biotechnology industry. This means that INSP’s stock grew somewhat faster than VIVO’s over the last 12 months.
VIVO's Price Growth Rating (38) in the Biotechnology industry is somewhat better than the same rating for INSP (93) in the Medical Specialties industry. This means that VIVO’s stock grew somewhat faster than INSP’s over the last 12 months.
VIVO's P/E Growth Rating (5) in the Biotechnology industry is significantly better than the same rating for INSP (99) in the Medical Specialties industry. This means that VIVO’s stock grew significantly faster than INSP’s over the last 12 months.
| INSP | VIVO | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 85% | 2 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 75% | 2 days ago 86% |
| Momentum ODDS (%) | 2 days ago 82% | 2 days ago 90% |
| MACD ODDS (%) | 2 days ago 79% | 2 days ago 90% |
| TrendWeek ODDS (%) | 2 days ago 79% | 2 days ago 84% |
| TrendMonth ODDS (%) | 2 days ago 85% | 2 days ago 86% |
| Advances ODDS (%) | 12 days ago 83% | 2 days ago 84% |
| Declines ODDS (%) | 2 days ago 77% | 6 days ago 90% |
| BollingerBands ODDS (%) | 2 days ago 86% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 76% | 2 days ago 81% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| BCICX | 10.66 | N/A | N/A |
| BlackRock Multi-Asset Income Investor C | |||
| GWSCX | 14.00 | N/A | N/A |
| Gabelli Focused Gr and Inc C | |||
| PQIIX | 15.26 | N/A | N/A |
| PIMCO Dividend and Income Institutional | |||
| ARYMX | 14.81 | N/A | N/A |
| American Century Global Real Estate A | |||
| TSMGX | 19.83 | N/A | N/A |
| Touchstone Sands Cptl Emerg Mkts Gr A | |||
INSP and
Correlation & Price change
A.I.dvisor indicates that over the last year, INSP has been loosely correlated with VIVO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if INSP jumps, then VIVO could also see price increases.
| Ticker / NAME | Correlation To INSP | 1D Price Change % | ||
|---|---|---|---|---|
| INSP | 100% | -2.06% | ||
| VIVO - INSP | 41% Loosely correlated | +6.62% | ||
| AZTA - INSP | 37% Loosely correlated | -6.56% | ||
| CSTL - INSP | 35% Loosely correlated | -3.88% | ||
| BRKR - INSP | 32% Poorly correlated | -2.02% | ||
| SIBN - INSP | 32% Poorly correlated | -5.22% | ||
More | ||||
VIVO and
Correlation & Price change
A.I.dvisor indicates that over the last year, VIVO has been loosely correlated with INSP. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if VIVO jumps, then INSP could also see price increases.
| Ticker / NAME | Correlation To VIVO | 1D Price Change % | ||
|---|---|---|---|---|
| VIVO | 100% | +6.62% | ||
| INSP - VIVO | 41% Loosely correlated | -2.06% | ||
| ICLR - VIVO | 38% Loosely correlated | -4.44% | ||
| BRKR - VIVO | 37% Loosely correlated | -2.02% | ||
| GMED - VIVO | 36% Loosely correlated | -1.63% | ||
| MLGO - VIVO | 35% Loosely correlated | N/A | ||
More | ||||